Sun.Apr 07, 2024

article thumbnail

For biopharma M&A, the best returns come from small deals: analysts

Fierce Pharma

Last year closed with a flurry of big-money biopharma deals. Of the industry’s top 10 acquisitions, six came in the fourth quarter. | Market research by McKinsey found that smaller, strategic M&A deals provide greater shareholder returns than multibillion-dollar acquisitions. Analysts from McKinsey and Project Farma explain why and offer advice on how to optimize deals.

Biopharma 267
article thumbnail

4 Lessons We Learned From The Change Healthcare Cyberattack

MedCity News

Healthcare industry leaders think there is much to learn from the Change Healthcare cyberattack, and they hope the sector can apply these lessons to prevent a hack like this from ever happening again. Overall, the chaotic aftermath of the attack underscores the dire need for a more unified approach to cybersecurity within the healthcare sector. The post 4 Lessons We Learned From The Change Healthcare Cyberattack appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Carvykti, Abecma move earlier in multiple myeloma treatment

pharmaphorum

FDA approves earlier use of J&J's BCMA CAR-T therapy Carvykti and BMS' rival Abecma for earlier use in multiple myeloma

FDA 82
article thumbnail

4 Things Digital Health Investors Look for in a Tight Funding Environment

MedCity News

There are four things that entrepreneurs need to demonstrate to investors to have fundraising success: a large total addressable market, strong unit economics and product-market fit, a world-class team, and a compelling plan for the future. The post 4 Things Digital Health Investors Look for in a Tight Funding Environment appeared first on MedCity News.

Marketing 120
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Explore Cell & Gene Therapy Bioanalysis and QC with Applied Biosystems Genetic Analysis Tools

PharmaTech

Explore QualTrak to find the right bioanalytical tools by modality, phase, and applications. Optimize biopharmaceutical drug development with suggested efficient workflows supported by consistent assays & reagents manufactured under GMP manufacturing principles, automated instruments, premium service & support, and a vertically integrated supply chain.

article thumbnail

Heali Contracts With California Medicaid, Unveils Medical Nutrition Therapy Tool

MedCity News

Heali’s new Medical Nutrition Therapy tool offers patients and providers access to a library of evidence-based dietary recommendations. The post Heali Contracts With California Medicaid, Unveils Medical Nutrition Therapy Tool appeared first on MedCity News.

Medical 114

More Trending

article thumbnail

Diagonal Therapeutics’ New Slant Attracts $128M to Reactivate Antibody Drug R&D

MedCity News

Diagonal Therapeutics develops agonist antibodies to treat rare cardiovascular conditions. Using artificial intelligence, the startup’s technology sorts through billions of antibody/receptor combinations to identify the ones that reactivate signaling pathways lost to disease. The post Diagonal Therapeutics’ New Slant Attracts $128M to Reactivate Antibody Drug R&D appeared first on MedCity News.

Biopharma 102
article thumbnail

Finding the Right Partner for Your Clinical Trial

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Exploring Treatment Options for Patients with Treatment-Resistant Schizophrenia

Pharmacy Times

Potential adjunctive and novel treatment options based on a patient's specific symptoms and clinical factors are being explored to treat treatment-resistant schizophrenia

article thumbnail

Cleaning and Disinfection in Sterile Drug Manufacturing

PharmaTech

Webinar Date/Time: Wed, May 15, 2024 2:00 PM EDT

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Novel Drugs Targeting Different Pathways Show Promise in Schizophrenia

Pharmacy Times

Developments in glycine transporter type 1 inhibitors, D-amino acid oxidase inhibitors, and phosphodiesterase inhibitors are pushing schizophrenia research forward.

article thumbnail

New Data Shows Positive Results for Sotagliflozin for Patients With Chronic Kidney Disease, Diabetes

Pharmacy Times

The abstracts will be presented at the American College of Cardiology Conference from April 6 to April 8, 2024, in Atlanta, Georgia.

article thumbnail

Expert: The Evolving Landscape of Pharmacologic Research and Clinical Management of Symptoms in Borderline Personality Disorder

Pharmacy Times

Expert perspective on current research, treatment approaches, and clinical considerations for pharmacologic management of borderline personality disorder

article thumbnail

Study: Empagliflozin Reduces MACE Regardless of Baseline Albuminuria Levels

Pharmacy Times

The results further confirm earlier findings from the EMPA-KIDNEY trial.

48
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten